MedTrace Logo

Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease

NCT06471803 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-06-25

No results posted yet for this study

Summary

The current biological issues driving the evolutionary progression of coronary artery disease are in focus: at this stage, the biological evidence for them is scarce and small in scale, with the exception of metabolomics and microbiomics. Issues such as histologic mapping of coronary atherosclerosis deterioration remain to be corroborated by more clinical and basic evidence! By analyzing the clinical data and multi-omics data of patients with coronary heart disease, investigators will explore the related risk factors and establish molecular subtypes and prognostic prediction models for individualized prediction of coronary heart disease risk, in order to guide the clinical screening of high-risk groups of coronary heart disease and formulate more targeted intervention countermeasures.

Conditions

  • Atherosclerotic Cardiovascular Diseases

Sponsors & Collaborators

  • Henan Province Clinical Research Center for Cardiovascular Diseases

    lead OTHER

Principal Investigators

  • Junnan Tang, Director · Department of Cardiology, The First Affiliated Hospital of Zhengzhou University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06471803 on ClinicalTrials.gov